Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease.

PubWeight™: 1.78‹?› | Rank: Top 3%

🔗 View Article (PMID 15694943)

Published in Atherosclerosis on February 01, 2005

Authors

Fabrice Bonnet1, Kate Irving, Jean-Louis Terra, Patrice Nony, François Berthezène, Philippe Moulin

Author Affiliations

1: Department of Medicine, Unit 11, Cardiovascular Hospital Louis Pradel, 69394 Lyon, France. fab.so.bonnet@free.fr

Articles citing this

Depression and cardiovascular disease: healing the broken-hearted. JAMA (2006) 2.44

Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. JAMA (2010) 2.16

Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med (2006) 1.57

Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis (2009) 1.21

Depressive symptoms, physical inactivity and risk of cardiovascular mortality in older adults: the Cardiovascular Health Study. Heart (2011) 1.19

Depression and coronary artery disease: the association, mechanisms, and therapeutic implications. Psychiatry (Edgmont) (2009) 1.10

Validation of the Stanford Brief Activity Survey: examining psychological factors and physical activity levels in older adults. J Phys Act Health (2010) 1.06

Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors. Br J Cancer (2006) 1.06

Atypical Epidemiologic Finding in Association between Depression and Alcohol Use or Smoking in Korean Male: Korean Longitudinal Study of Aging. Psychiatry Investig (2014) 0.96

Scared to death: results from the Health, Aging, and Body Composition study. Am J Geriatr Psychiatry (2007) 0.94

Domain specific self-efficacy mediates the impact of pain catastrophizing on pain and disability in overweight and obese osteoarthritis patients. J Pain (2008) 0.93

Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril (2010) 0.92

Association between depression and peripheral artery disease: insights from the heart and soul study. J Am Heart Assoc (2012) 0.91

Understanding the relationship between stress, distress and healthy lifestyle behaviour: a qualitative study of patients and general practitioners. BMC Fam Pract (2013) 0.91

Persistent depressive symptoms and functional decline among patients with peripheral arterial disease. Psychosom Med (2007) 0.90

Antidepressant use and diabetes mellitus risk: a meta-analysis. Korean J Fam Med (2013) 0.89

Fruit and vegetable consumption and prevalence and incidence of depressive symptoms in mid-age women: results from the Australian longitudinal study on women's health. Eur J Clin Nutr (2014) 0.84

Association of Hearing Impairment With Incident Frailty and Falls in Older Adults. J Aging Health (2015) 0.84

Exercise and Mental Health: What did We Learn in the Last 20 Years? Front Psychiatry (2014) 0.83

Association between anxiety and hypertension: a systematic review and meta-analysis of epidemiological studies. Neuropsychiatr Dis Treat (2015) 0.81

Consequences of Comorbidity of Elevated Stress and/or Depressive Symptoms and Incident Cardiovascular Outcomes in Diabetes: Results From the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. Diabetes Care (2015) 0.81

Stress resilience and subsequent risk of type 2 diabetes in 1.5 million young men. Diabetologia (2016) 0.81

Primary care-based educational interventions to decrease risk factors for metabolic syndrome for adults with major psychotic and/or affective disorders: a systematic review. Syst Rev (2013) 0.81

Associations between depression subtypes, depression severity and diet quality: cross-sectional findings from the BiDirect Study. BMC Psychiatry (2015) 0.80

Harm avoidance and cerebral infarction. Neuropsychology (2013) 0.80

Combined Healthy Lifestyle Is Inversely Associated with Psychological Disorders among Adults. PLoS One (2016) 0.79

Higher anti-depressant dose and major adverse outcomes in moderate chronic kidney disease: a retrospective population-based study. BMC Nephrol (2014) 0.79

Depression and Anxiety Screens as Simultaneous Predictors of 10-Year Incidence of Diabetes Mellitus in Older Adults in Primary Care. J Am Geriatr Soc (2016) 0.79

Eating and psychological profiles of women with higher depressive symptoms who are trying to lose weight. J Obes (2012) 0.78

Exercise as Treatment for Anxiety: Systematic Review and Analysis. Ann Behav Med (2015) 0.78

Late-life depression and cardiovascular disease burden: examination of reciprocal relationship. Am J Geriatr Psychiatry (2014) 0.78

Serum inflammatory cytokines and depression in coronary artery disease. Iran Red Crescent Med J (2014) 0.78

Psychosocial Factors Associated with Subclinical Atherosclerosis in South Asians: The MASALA Study. J Immigr Minor Health (2016) 0.77

Perturbation of mitiglinide metabolism by chronic unpredicted mild stress in rats. Sci Rep (2014) 0.77

The role of inflammatory markers in explaining the association between depression and cardiovascular hospitalisations. J Behav Med (2015) 0.77

Association between major depression and cardiovascular risk: the role of antidepressant medication. Psychopharmacology (Berl) (2016) 0.77

Probable insomnia is associated with future total energy intake and diet quality in men. Am J Clin Nutr (2016) 0.76

Low stress resilience in late adolescence and risk of hypertension in adulthood. Heart (2016) 0.75

Anxiety after completion of treatment for early-stage breast cancer: a systematic review to identify candidate predictors and evaluate multivariable model development. Support Care Cancer (2017) 0.75

Reduced fractional anisotropy in patients with major depressive disorder and associations with vascular stiffness. Neuroimage Clin (2017) 0.75

Effect of Physical Activity on the Relation Between Psychosocial Factors and Cardiovascular Events (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol (2016) 0.75

Randomised controlled trial of a 12 week yoga intervention on negative affective states, cardiovascular and cognitive function in post-cardiac rehabilitation patients. BMC Complement Altern Med (2014) 0.75

Depression and Anxiety after Acute Myocardial Infarction Treated by Primary PCI. PLoS One (2016) 0.75

Anxiety Disorders and Cardiovascular Disease. Curr Psychiatry Rep (2016) 0.75

Association between Work-Related Stress and Risk for Type 2 Diabetes: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. PLoS One (2016) 0.75

"Blues" ain't good for the heart. Indian J Psychiatry (2011) 0.75

Comment on "Atypical Epidemiologic Finding in Association between Depression and Alcohol Use or Smoking in Korean Male: Korean Longitudinal Study of Aging". Psychiatry Investig (2015) 0.75

The Impact of Medication Nonadherence on the Relationship Between Mortality Risk and Depression in Heart Failure. Health Psychol (2017) 0.75

Relationship between Chronic Kidney Disease and Depression in Elderly Koreans Using the 2013 Korea National Health and Nutrition Examination Survey Data. Korean J Fam Med (2017) 0.75

Effects of Caregiving Status and Changes in Depressive Symptoms on Development of Physical Morbidity Among Long-Term Cancer Caregivers. Health Psychol (2017) 0.75

Articles by these authors

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet (2003) 11.67

Reverse osmosis desalination: water sources, technology, and today's challenges. Water Res (2009) 1.80

Experimental designs for small randomised clinical trials: an algorithm for choice. Orphanet J Rare Dis (2013) 1.77

Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry (2007) 1.70

A comparison of the NCEP-ATPIII, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: evidence for sex-specific differences. Atherosclerosis (2006) 1.66

Noninvasive measurement of carotid extra-media thickness: associations with cardiovascular risk factors and intima-media thickness. JACC Cardiovasc Imaging (2009) 1.58

Determinants of torsades de pointes in older patients with drug-associated long QT syndrome: a case-control study. Drugs Aging (2014) 1.50

Compliance-guided therapy : a new insight into the potential role of clinical pharmacologists. Clin Pharmacokinet (2006) 1.50

Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs. Arch Cardiovasc Dis (2009) 1.40

Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J Clin Invest (2005) 1.37

Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects. Diabetes Care (2005) 1.22

Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry (2014) 1.21

Intronic mutations outside of Alu-repeat-rich domains of the LDL receptor gene are a cause of familial hypercholesterolemia. Hum Genet (2002) 1.14

Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. Diabetes (2004) 1.12

Activation of p38 mitogen-activated protein kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets. Free Radic Biol Med (2003) 1.11

Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiogr (2011) 1.09

Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: a speckle-tracking imaging study. J Am Soc Echocardiogr (2010) 1.09

Parity and carotid atherosclerosis in men and women: insights into the roles of childbearing and child-rearing. Stroke (2009) 1.04

GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia. J Clin Endocrinol Metab (2011) 1.02

Bridging the gap between therapeutic research results and physician prescribing decisions: knowledge transfer, a prerequisite to knowledge translation. Eur J Clin Pharmacol (2004) 1.01

New insights on the relation between untreated and treated outcomes for a given therapy effect model is not necessarily linear. J Clin Epidemiol (2007) 0.98

Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome. J Hypertens (2005) 0.94

Association of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients. Clin Chim Acta (2008) 0.94

The association between dietary macronutrient intake and the prevalence of the metabolic syndrome. Br J Nutr (2008) 0.93

Longitudinal displacement of the carotid wall and cardiovascular risk factors: associations with aging, adiposity, blood pressure and periodontal disease independent of cross-sectional distensibility and intima-media thickness. Ultrasound Med Biol (2012) 0.93

Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT). Atherosclerosis (2008) 0.91

Measurement of two-dimensional movement parameters of the carotid artery wall for early detection of arteriosclerosis: a preliminary clinical study. Ultrasound Med Biol (2011) 0.91

Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor compliance. Clin Pharmacokinet (2002) 0.91

Echocardiographic evidence for valvular toxicity of benfluorex: a double-blind randomised trial in patients with type 2 diabetes mellitus. PLoS One (2012) 0.90

SCORE should be preferred to Framingham to predict cardiovascular death in French population. Eur J Cardiovasc Prev Rehabil (2009) 0.89

Increased lipid peroxidation in LDL from type-2 diabetic patients. Lipids (2010) 0.89

Revisiting the relationship between baseline risk and risk under treatment. Emerg Themes Epidemiol (2009) 0.89

Contrast-enhanced MR angiography of the foot: anatomy and clinical application in patients with diabetes. AJR Am J Roentgenol (2004) 0.88

Clinical trial simulation using therapeutic effect modeling: application to ivabradine efficacy in patients with angina pectoris. J Pharmacokinet Pharmacodyn (2002) 0.88

The global risk approach should be better applied in French hypertensive patients: a comparison between simulation and observation studies. PLoS One (2011) 0.87

Carotid intima-media and adventitial thickening: comparison of new and established ultrasound and magnetic resonance imaging techniques. Atherosclerosis (2011) 0.87

Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening. Trials (2011) 0.87

Evaluation of a Kalman-based block matching method to assess the bi-dimensional motion of the carotid artery wall in B-mode ultrasound sequences. Med Image Anal (2013) 0.86

Alteration in lipoprotein lipase activity bound to triglyceride-rich lipoproteins in the postprandial state in type 2 diabetes. J Lipid Res (2004) 0.85

Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease. Tohoku J Exp Med (2007) 0.85

Evaluation of two evidence-based knowledge transfer interventions for physicians. A cluster randomized controlled factorial design trial: the CardioDAS Study. Fundam Clin Pharmacol (2007) 0.84

A controlled study of consumption of beta-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects. Br J Nutr (2009) 0.84

Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers. Orphanet J Rare Dis (2010) 0.84

Postprandial increase of plasma apoAV concentrations in Type 2 diabetic patients. Atherosclerosis (2005) 0.83

Modes of rationality in nursing documentation: biology, biography and the 'voice of nursing'. Nurs Inq (2005) 0.83

The reliability of high resolution MRI in the measurement of early stage carotid wall thickening. J Cardiovasc Magn Reson (2007) 0.83

Identification of two novel mutations and long-term follow-up in abetalipoproteinemia: a report of four cases. Eur J Pediatr (2008) 0.83

Noninvasive assessment of the prevalence and characteristics of coronary atherosclerotic plaques by multidetector computed tomography in asymptomatic type 2 diabetic patients at high risk of significant coronary artery disease: a preliminary study. Arch Cardiovasc Dis (2009) 0.83

Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapy. Atherosclerosis (2008) 0.83

Quantitative prediction of the impact of drug interactions and genetic polymorphisms on cytochrome P450 2C9 substrate exposure. Clin Pharmacokinet (2013) 0.83

Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia. J Clin Endocrinol Metab (2005) 0.83

Simultaneous extraction of carotid artery intima-media interfaces in ultrasound images: assessment of wall thickness temporal variation during the cardiac cycle. Int J Comput Assist Radiol Surg (2014) 0.81

How should therapeutic information be transferred to users? Fundam Clin Pharmacol (2003) 0.81

In vitro glycoxidized low-density lipoproteins and low-density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated protein kinase. J Clin Endocrinol Metab (2007) 0.80

Inhibitory effects of in vivo oxidized high-density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia. FASEB J (2013) 0.80

New tools to measure discrepancy between prescribing practices and guideline recommendations. J Eval Clin Pract (2007) 0.80

Expression of simian CETP in normolipidemic Fisher rats has a profound effect on large sized apoE-containing HDL. J Lipid Res (2002) 0.80

Towards a nursing minimum data set for Ireland: making Irish nursing visible. J Adv Nurs (2006) 0.80

Prevalence and function of anti-lipoprotein lipase auto-antibodies in type V hyperchylomicronemia. Atherosclerosis (2009) 0.79

Revisiting the level of evidence in randomized controlled clinical trials: A simulation approach. Contemp Clin Trials (2009) 0.79

[Hypertriglyceridemia: therapeutic strategy]. Rev Prat (2011) 0.78

Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects. PLoS One (2014) 0.77

Effect of cholesteryl ester transfer protein (CETP) expression on diet-induced hyperlipidemias in transgenic rats. Atherosclerosis (2005) 0.77

Low cholesteryl ester transfer protein (CETP) concentration but normal CETP activity in serum from patients with short-term hypothyroidism Lack of relationship to lipoprotein abnormalities. Clin Endocrinol (Oxf) (2003) 0.77

Glycoxidized HDL, HDL enriched with oxidized phospholipids and HDL from diabetic patients inhibit platelet function. J Clin Endocrinol Metab (2015) 0.77

Relation between XbA1 apolipoprotein B gene polymorphism and cardiovascular risk in a type 2 diabetic cohort. Atherosclerosis (2004) 0.76

Getting evidence to prescribers and patients or how to make EBM a reality. Stud Health Technol Inform (2003) 0.75

Bis(monoacylglycero)phosphate accumulation in macrophages induces intracellular cholesterol redistribution, attenuates liver-X receptor/ATP-Binding cassette transporter A1/ATP-binding cassette transporter G1 pathway, and impairs cholesterol efflux. Arterioscler Thromb Vasc Biol (2013) 0.75

CEPHEUS Trial. Arch Cardiovasc Dis (2008) 0.75

Women were included twice in a meta-analysis. Am J Med (2011) 0.75

A methodological framework for drug development in rare diseases. Orphanet J Rare Dis (2014) 0.75

Efficacy and safety of more intensive lowering of LDL cholesterol. Lancet (2011) 0.75

How to measure non-consistency of medical practices with available evidence in therapeutics: a methodological framework. Fundam Clin Pharmacol (2005) 0.75

[New approaches in pharmacology: numerical modelling and simulation]. Therapie (2005) 0.75

[Screening of silent myocardial ischemia in diabetic patients: Practical details and issues]. Presse Med (2011) 0.75

[Psymobile and the phenomenon of the hikikomori]. Soins Psychiatr (2015) 0.75

[[DPP4 inhibitors: which cardiovascular risk?]]. Rev Prat (2015) 0.75

A short nocturnal activity scale used by nurses to evaluate hospitalized patients with dementia. J Am Geriatr Soc (2009) 0.75

A review of contemporary work on the ethics of ambient assisted living technologies for people with dementia. Sci Eng Ethics (2014) 0.75

Developing a data dictionary for the irish nursing minimum dataset. Stud Health Technol Inform (2006) 0.75

Alterations in the transfer of phospholipids from very-low density lipoproteins to activated platelets in type 2 diabetes. Atherosclerosis (2008) 0.75

Use of margarine enriched in phytosterols by patients at high cardiovascular risk and treated by hypolipidemic drugs. Nutr Metab Cardiovasc Dis (2006) 0.75

Effect of antiscalants on precipitation of an RO concentrate: metals precipitated and particle characteristics for several water compositions. Water Res (2010) 0.75

High density lipoprotein-anionic peptide factor effect on reverse cholesterol transport in type 2 diabetic patients with and without coronary artery disease. Clin Biochem (2010) 0.75

Bioequivalence evaluation of a fixed combination of chloroquine and proguanil in a capsule formulation versus a standard medication. Arzneimittelforschung (2002) 0.75

Editorial: delirium. Int J Older People Nurs (2006) 0.75

Support networks of older people living in the community. Int J Older People Nurs (2008) 0.75

[Arterial risk in type 2 diabetes: from mega-trials to prescription]. Rev Prat (2003) 0.75

The effect of antiscalant addition on calcium carbonate precipitation for a simplified synthetic brackish water reverse osmosis concentrate. Water Res (2010) 0.75